The Experts below are selected from a list of 54993 Experts worldwide ranked by ideXlab platform
Pascal Guggenbuhl - One of the best experts on this subject based on the ideXlab platform.
-
Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: A literature review.
Joint Bone Spine, 2013Co-Authors: Guillaume Coiffier, Béatrice Bouvard, Florence Chopin, Emmanuel Biver, Thomas Funck-brentano, Garnero Patrick, Pascal GuggenbuhlAbstract:We studied the impact of inflammatory Rheumatism and its treatment on the most common bone turnover markers, based on six previously defined questions in a systematic literature review in order to define their place in daily clinical practice. The role of bone is currently considered of particular importance concerning cartilage damage in inflammatory Rheumatism (rheumatoid arthritis and ankylosing spondylitis) and the new concept of osteoimmunology has emerged. Some bone turnover markers are available in clinical practice. In spite of rich and extensive literature on bone turnover markers, their use in inflammatory Rheumatism or even osteoporosis is not clear, and a systematic literature review became necessary. In spite of a large number of different markers used in literature, few of them that are useful in common practice have been studied in the field of inflammatory Rheumatism such as rheumatoid arthritis and ankylosing spondylitis. Although their study enables understanding of the physiopathological mechanisms of osteoporosis in inflammatory Rheumatism, their use in current common practice cannot be recommended. Interesting data on the forecast of the structural evolution of rheumatoid arthritis has been found within the framework of clinical research, without any real practical impact today.
Guillaume Coiffier - One of the best experts on this subject based on the ideXlab platform.
-
Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: A literature review.
Joint Bone Spine, 2013Co-Authors: Guillaume Coiffier, Béatrice Bouvard, Florence Chopin, Emmanuel Biver, Thomas Funck-brentano, Garnero Patrick, Pascal GuggenbuhlAbstract:We studied the impact of inflammatory Rheumatism and its treatment on the most common bone turnover markers, based on six previously defined questions in a systematic literature review in order to define their place in daily clinical practice. The role of bone is currently considered of particular importance concerning cartilage damage in inflammatory Rheumatism (rheumatoid arthritis and ankylosing spondylitis) and the new concept of osteoimmunology has emerged. Some bone turnover markers are available in clinical practice. In spite of rich and extensive literature on bone turnover markers, their use in inflammatory Rheumatism or even osteoporosis is not clear, and a systematic literature review became necessary. In spite of a large number of different markers used in literature, few of them that are useful in common practice have been studied in the field of inflammatory Rheumatism such as rheumatoid arthritis and ankylosing spondylitis. Although their study enables understanding of the physiopathological mechanisms of osteoporosis in inflammatory Rheumatism, their use in current common practice cannot be recommended. Interesting data on the forecast of the structural evolution of rheumatoid arthritis has been found within the framework of clinical research, without any real practical impact today.
P L C M Van Riel - One of the best experts on this subject based on the ideXlab platform.
-
development and validation of the european league against Rheumatism response criteria for rheumatoid arthritis comparison with the preliminary american college of rheumatology and the world health organization international league against Rheumatism
Arthritis & Rheumatism, 1996Co-Authors: A M Van Gestel, M L L Prevoo, M H Van Rijswijk, L B A Van De Putte, P L C M Van RielAbstract:Objective. To validate the European League Against Rheumatism (EULAR), the American College of Rheumatology (ACR), and the World Health Organization (WHO)/International League Against Rheumatism (ILAR) response criteria for rheumatoid arthritis (RA). Methods. EULAR response criteria were developed combining change from baseline and level of disease activity attained during followup. In a trial comparing hydroxychloroquine and sulfasalazine, we studied construct (radiographic progression), criterion (functional capacity), and discriminant validity. Results. EULAR response criteria had good construct, criterion, and discriminant validity. ACR and WHO/ILAR criteria showed only good criterion validity. Conclusion. EULAR response criteria showed better construct and discriminant validity than did the ACR and the WHO/ILAR response criteria for RA.
Thao Pham - One of the best experts on this subject based on the ideXlab platform.
-
Practical management of patients on Janus kinase inhibitor (JAKi) therapy - the CRI fact sheets
Joint Bone Spine, 2019Co-Authors: Christophe Richez, Jacques Morel, Jean Sibilia, Thao PhamAbstract:Practical fact sheets drawn up by the Rheumatism and Inflammation Club (CRI), a group endorsed by the French Society for Rheumatology (SFR)
Garnero Patrick - One of the best experts on this subject based on the ideXlab platform.
-
Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: A literature review.
Joint Bone Spine, 2013Co-Authors: Guillaume Coiffier, Béatrice Bouvard, Florence Chopin, Emmanuel Biver, Thomas Funck-brentano, Garnero Patrick, Pascal GuggenbuhlAbstract:We studied the impact of inflammatory Rheumatism and its treatment on the most common bone turnover markers, based on six previously defined questions in a systematic literature review in order to define their place in daily clinical practice. The role of bone is currently considered of particular importance concerning cartilage damage in inflammatory Rheumatism (rheumatoid arthritis and ankylosing spondylitis) and the new concept of osteoimmunology has emerged. Some bone turnover markers are available in clinical practice. In spite of rich and extensive literature on bone turnover markers, their use in inflammatory Rheumatism or even osteoporosis is not clear, and a systematic literature review became necessary. In spite of a large number of different markers used in literature, few of them that are useful in common practice have been studied in the field of inflammatory Rheumatism such as rheumatoid arthritis and ankylosing spondylitis. Although their study enables understanding of the physiopathological mechanisms of osteoporosis in inflammatory Rheumatism, their use in current common practice cannot be recommended. Interesting data on the forecast of the structural evolution of rheumatoid arthritis has been found within the framework of clinical research, without any real practical impact today.
